A blog bringing you perspectives from the frontlines of the drug pricing debate.

Seniors, Taxpayers Will Face Billions in Higher Drug Costs Without Rebates

President Trump has signed an Executive Order to eliminate drug rebates in Medicare Part D, after the Administration…

Georgia Legislators Should Preserve Tools to Lower Drug Prices

Published in The Newnan Times-Herald As COVID-19 continues to impact the nation, Georgia’s Governor and state legislature are…

New Study Shows Big Pharma’s Prices Push Drug Costs Higher

Anyone following the U.S. drug pricing debate knows that “drug prices” are complicated. Most brand-name prescription drugs sold…

PBMs Providing Patient Access to Medicine During COVID-19

Today, millions of Americans are staying home during the threat of COVID-19. Access to affordable prescription drugs remains…

Tapping into the Generic Pipeline in 2020: Savings for Consumers

Three months into 2020 and the prescription drug pricing crisis continues to grow; in January alone, drug manufacturers…

Drug Pricing: Questions for the Presidential Candidates

With the Iowa caucuses and New Hampshire primary taking the spotlight, national attention on the presidential race and…

Pharmacy Benefit Managers Are Key to Helping Retirees

Published in Morning Consult  With the United States in a debate on high drug prices, solutions are being…

Health Care Purchasers Call on Congress to Take Action to Boost Competition

By Debra Barrett, Coalition for Affordable Prescription Drugs, James Gelfand, ERIC and Andrew MacPherson, Public Sector HealthCare Roundtable…

Creating a Competitive Marketplace that Works for Patients

U.S. patients, payors and the health care system are spending billions of dollars more on prescription drugs than…

Meaningful Transparency

As policymakers seek to address widespread concern about high drug prices, the conversation often includes a call for…